CERTICOEUR: A Secondary Prevention Study of Skin Cancers in Heart Transplant Patients. Everolimus Versus Calcineurin Inhibitors Multicenter Trial
NCT00799188
Cardiac Transplantation, Neoplasms
Lyon, France
View Trial DetailsNCT Number: NCT02255123
This study is a multicenter, non-randomized, retrospective study to collect long term (4 years post-transplant) clinical outcome data on subjects previously enrolled in the CTOT-05 study (NCT00466804) to evaluate participant and graft survival.
Looking for future studies?
Notify MeAll sexes
Observational
University of California at San Francisco, San Francisco, California, United States
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: 48 months (+/- 6 months) after primary transplantation
Coronary Artery Vasculopathy (CAV)
International Society for Heart and Lung Transplantation Registry (ISHLT)
Time frame: 48 months (+/- 6 months) after primary transplantation
Time frame: 48 months (+/- 6 months) after primary transplantation
Time frame: 48 months (+/- 6 months) after primary transplantation
Time frame: 48 months (+/- 6 months) after primary transplantation
Time frame: 48 months (+/- 6 months) after primary transplantation
Coronary Artery Vasculopathy (CAV)
International Society for Heart and Lung Transplantation Registry (ISHLT)
National Institute of Allergy and Infectious Diseases (NIAID)
Nih
A Retrospective Multicenter Study to Determine 4-Year Clinical Outcomes in Subjects Previously Enrolled in the CTOT-05 Study (CTOT-18)
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT00799188
Cardiac Transplantation, Neoplasms
Lyon, France
View Trial DetailsNCT02672683
Cardiac Transplantation
Paris, France
View Trial DetailsNCT03145441
Cardiac Transplantation, Cardiopulmonary Bypass
Budapest, Hungary
View Trial DetailsNCT00716573
Cardiac Transplantation, Chronic Disease
Lyon, France
View Trial Details